Table 2

Prevalence rates of refractive errors among adults in population-based eye studies

StudyBeaver Dam USA5Blue Mountains Australia1Singapore Malay Population7Singapore Indian Population11Tajimi Japan4Beijing China6Handan China16Central India18Bangladesh19Barbados20Norfolk GB9Segovia Spain8Gutenberg Health Study Germany
Subjects (n)2354365429743400302144396491471111 6244036251941713 959
Age span43–8449–9740–8040+40+40–9030+30+30+40–8448–8840–7935–74
Myopia (<−0.5 sph D)26.2% (95% CI NA)15.5% (12.4 to 18.6)30.7% (95% CI NA)28.0% (25.8 to 30.2)41.8% (40.0 to 43.6)22.9% (21.7 to 24.2)26.7% (25.6 to 27.8)17.0% (16.4 to 17.6)22.1% (21.3 to 22.8)21.9% (20.6 to 23.2)27.0% (95% CI NA)25.4% (21.5 to 29.8)35.1% (34.3 to 35.9)
Hyperopia (>+0.5 sph D)49.0% (95% CI NA)56.6% (54.4to 58.8)27.4% (24.7 to 27.6)35.9% (33.7 to 38.3)27.9% (26.3 to 29.6)20.0% (18.8 to 21.2)15.9% (15.0 to 16.8)18.0% (17.4 to 18.6)20.6% (19.9 to 21.4)46.9% (45.4 to 48.5)52.2% (95% CI NA)43.6% (39.0 to 48.4)31.8% (31.0 to 32.6)
Astigmatism (>0.5 cyl D)NANA33.3% (33.0 to 33.5)54.9% (52.0 to 57.9)54.0% (52.1 to 55.8)NA24.5% (23.5 to 25.5)NA32.4% (31.5 to 33.3)NANA53.5% (48.7 to 58.2)32.3% (31.6 to 33.1)
Anisometropia (>1 sph D difference)NANA9.9% (9.7 to 10.0)9.8% (8.6 to 11.115.1% (13.7 to 16.4)NA7.7% (7.0 to 8.4)NA7.5% (7.0 to 8.0)NANA12.3% (95% CI NA)13.5% (12.9 to 14.0)
  • NA=not available.